United Therapeutics's market cap is currently $16.64B. The company's EPS TTM is $22.769; its P/E ratio is 16.72; United Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $6.56. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.33B	$ 1.94B	$ 1.69B	$ 1.48B	$ 1.45B
Gross Profit	$ 2.07B	$ 1.79B	$ 1.56B	$ 1.38B	$ 1.33B
Operating Income	$ 1.18B	$ 979.70M	$ 555.90M	$ 593.60M	$ -187.60M
EBITDA	$ 1.39B	$ 1.04B	$ 736.80M	$ 646.30M	$ -74.90M
Net Income	$ 984.80M	$ 727.30M	$ 475.80M	$ 514.80M	$ -104.50M
Balance Sheet
Cash & Short-Term Investments	$ 2.99B	$ 4.15B	$ 3.58B	$ 2.98B	$ 2.25B
Total Assets	$ 7.17B	$ 6.04B	$ 5.17B	$ 4.62B	$ 3.91B
Total Debt	$ 700.00M	$ 800.00M	$ 800.00M	$ 800.00M	$ 850.00M
Net Debt	$ -507.70M	$ -161.20M	$ -94.80M	$ 61.30M	$ 111.60M
Total Liabilities	$ 1.18B	$ 1.25B	$ 1.21B	$ 1.22B	$ 1.13B
Stockholders' Equity	$ 5.98B	$ 4.80B	$ 3.96B	$ 3.40B	$ 2.78B
Cash Flow
Free Cash Flow	$ 747.60M	$ 663.70M	$ 477.40M	$ 696.40M	$ -290.30M
Operating Cash Flow	$ 978.00M	$ 802.50M	$ 598.20M	$ 755.70M	$ -206.60M
Investing Cash Flow	$ -719.60M	$ -811.50M	$ -486.90M	$ -738.50M	$ -335.40M
Financing Cash Flow	$ -11.90M	$ 75.40M	$ 44.80M	$ -16.90M	$ 611.20M

Currency in USD

United Therapeutics Earnings and Revenue History

Income Statement >

United Therapeutics Debt to Assets

Balance Sheet >

United Therapeutics Cash Flow

Cash Flow >

United Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing